Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Fluorometholone acetate
Clinical data | |
---|---|
Trade names | Flarex, Florate, Omnitrol |
Other names | Oxylone acetate; 1-Dehydro-9α-fluoro-11β,17α-dihydroxy-6α-methylprogesterone 17α-acetate; 17α-Acetoxy-9α-fluoro-11β-hydroxy-6α-methylpregna-1,4-diene-3,20-dione |
Drug class | Corticosteroid; Glucocorticoid; Progestogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.021.156 |
Chemical and physical data | |
Formula | C24H31FO5 |
Molar mass | 418.505 g·mol−1 |
3D model (JSmol) | |
| |
|
Fluorometholone acetate, also known as oxylone acetate and sold under the brand names Flarex, Florate, and Omnitrol, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester, as well as a progestogen and progestogen ester. It is the C17α acetate ester of fluorometholone.
In addition to its potent corticosteroid activity, fluorometholone acetate is a progestogen. It has been studied in the treatment of breast cancer in women and has been found to be effective, producing remission in about 20% of women with advanced breast cancer at an oral dosage of 50 mg/day. However, it also produces severe Cushing's syndrome-like symptoms like plethora, moon face, glycosuria, marked weight gain, hypertension, and osteoporosis at this dosage due to its glucocorticoid activity.
See also
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||